2015, Number 2
<< Back Next >>
Rev Cubana Hematol Inmunol Hemoter 2015; 31 (2)
Chronic Myeloid Leukemia in a patient with sickle cell anemia
Quintero-Sierra Y, Hernández-Padrón C, Mustelier-Celza GL, Roque-García W, Blanco CA
Language: Spanish
References: 10
Page: 211-213
PDF size: 43.63 Kb.
Text Extraction
No abstract.
REFERENCES
Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U. Enfermedades de células falciformes y trastornos relacionados. William´s Hematología. 6th ed. Madrid:MARBÁN, S.L. 2007. p. 447-64.
Expósito YC, Agramonte OM, Miguel M. Drepanocitosis y cáncer: un camino hacia nuevas investigaciones. Rev Cub Hematol, Inmunol, Hemoter. 2014;30(3):202-13.
Stankovic KS, Brigitte T, Garandeau E, Lecomte I, Bachmeyer C, Lionnet F. Chronic myeloid leukaemia and sickle cell disease: could imatinib prevent vasoocclusive crisis? Br J Haematol. 2011;155:271–2.
Sallam MM, Alsuliman AM, Alahmed HE, Alabdulaali MK. Chronic myelogenous leukemia in sickle cell/beta 0-thalassemia.Indian J Pathol Microbiol. 2011 Jul- Sep;54(3):597-8.
Rosner F, Grünwald HW. Chronic granulocytic leukemia in a patient with hemoglobin SC disease. Am J Hematol. 1989 Aug;31(4):302
Phillips G J, Hartman J, Kinney TR, Sokal JE, Kaufman RE. Chronic granulocytic leukemia in a patient with sickle cell anemia. Am J Med. 1988 Oct;85(4):567-9.
Sarma PS, Chawda BK, Das SR. Chronic myelocytic leukaemia in a patient with sickle cell anaemia. J Assoc Physicians India. 1986 Nov;34(11):821-2.
Chen L, Zhuang M, Shah HQ, Lin JH. Chronic Myelogenous Leukemia in Sickle Cell Anemia. Arch Pathol Lab Med. 2005;129:423-4.
Goldsmith JC, Bonham VL, Steinberg MH. Framing the research agenda for sickle cell trait: building on the current understanding of clinical events and their potential implications. Am J Hematol. 2012 March;87(3):340–6.
Murphy M, Close J, Lottenberg R, Rajasekhar A. Effectiveness of Imatinib Therapy for Sickle Cell Anemia and Chronic Myeloid Leukemia. Am J Med Scienc. 2014 March;347(3):254-5. doi: 10.1097/MAJ.0000000000000228.
Full text